In-vivo sentinel lymph node mapping in patients with colorectal cancer

In-vivo sentinel lymph node mapping in patients with colorectal cancer - Sentinel lymph node mapping in patients with colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30234

Enrollment

Registered

2007-01-08

Start date

2006-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Colorectal carcinoma Age > 18 years No metastases Fit for treatment

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

Measure	Time frame
1. To define whether SLNM can adequately identified nodal involvement in CRC 2. To define detection rate (upstaging) and aberrant nodal drainage.	—

Secondary

Measure	Time frame
1. To determine which factors may influence the concept of SLN, such as tumorsize, location etc.	—

Countries

Netherlands

Outcome results